Literature DB >> 18024961

The Diacylglycerol-dependent translocation of ras guanine nucleotide-releasing protein 4 inside a human mast cell line results in substantial phenotypic changes, including expression of interleukin 13 receptor alpha2.

Gregory P Katsoulotos1, Miao Qi, Jian Cheng Qi, Kumiko Tanaka, William E Hughes, Timothy J Molloy, Roberto Adachi, Richard L Stevens, Steven A Krilis.   

Abstract

Ras guanine nucleotide-releasing protein 4 (RasGRP4) is a mast cell (MC)-restricted guanine nucleotide exchange factor and diacylglycerol (DAG)/phorbol ester receptor. An RasGRP4-defective variant of the human MC line HMC-1 was used to create stable clones expressing green fluorescent protein-labeled RasGRP4 for monitoring the movement of this protein inside MCs after exposure to phorbol 12-myristate 13-acetate (PMA), and for evaluating the protein's ability to control gene expression. RasGRP4 resided primarily in the cytosol. After exposure to PMA, RasGRP4 quickly translocated to the inner leaflet of the cell's plasma membrane. 15-30 min later, this signaling protein translocated from the plasma membrane to other intracellular sites. The translocation of RasGRP4 from the cytosol to its varied membrane compartments was found to be highly dependent on Phe(548) in the protein's C1 DAG/PMA-binding domain. Extracellular signal-regulated kinases 1 and 2 were activated during this translocation process, and c-kit/CD117 was lost from the cell's surface. Transcript-profiling approaches revealed that RasGRP4 profoundly regulated the expression of hundreds of genes in HMC-1 cells. For example, the expression of the transcript that encodes the interleukin (IL) 13 receptor IL-13Ralpha2 increased 61- to 860-fold in RasGRP4-expressing HMC-1 cells. A marked increase in IL-13Ralpha2 protein levels also was found. The accumulated data suggest RasGRP4 translocates to varied intracellular compartments via its DAG/PMA-binding domain to regulate signaling pathways that control gene and protein expression in MCs, including the cell's ability to respond to IL-13.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18024961     DOI: 10.1074/jbc.M707042200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  GPCR activation of Ras and PI3Kc in neutrophils depends on PLCb2/b3 and the RasGEF RasGRP4.

Authors:  Sabine Suire; Charlotte Lécureuil; Karen E Anderson; George Damoulakis; Izabella Niewczas; Keith Davidson; Hervé Guillou; Dingxin Pan; Len Stephens
Journal:  EMBO J       Date:  2012-07-18       Impact factor: 11.598

2.  The role of Ras guanine nucleotide releasing protein 4 in Fc epsilonRI-mediated signaling, mast cell function, and T cell development.

Authors:  Minghua Zhu; Deirdre M Fuller; Weiguo Zhang
Journal:  J Biol Chem       Date:  2012-01-19       Impact factor: 5.157

3.  Ras guanine nucleotide-releasing protein-4 (RasGRP4) involvement in experimental arthritis and colitis.

Authors:  Roberto Adachi; Steven A Krilis; Peter A Nigrovic; Matthew J Hamilton; Kyungemee Chung; Shakeel M Thakurdas; Joshua A Boyce; Paul Anderson; Richard L Stevens
Journal:  J Biol Chem       Date:  2012-04-16       Impact factor: 5.157

4.  Regulation and Function of the RasGRP Family of Ras Activators in Blood Cells.

Authors:  James C Stone
Journal:  Genes Cancer       Date:  2011-03

5.  Signal transduction pathways in chronic inflammatory autoimmune disease: small GTPases.

Authors:  Kris A Reedquist; Paul P Tak
Journal:  Open Rheumatol J       Date:  2012-09-07

6.  Aberrant splicing of the hRasGRP4 transcript and decreased levels of this signaling protein in the peripheral blood mononuclear cells in a subset of patients with rheumatoid arthritis.

Authors:  Toko Hashimoto; Shinsuke Yasuda; Hideyuki Koide; Hiroshi Kataoka; Tetsuya Horita; Tatsuya Atsumi; Takao Koike
Journal:  Arthritis Res Ther       Date:  2011-09-20       Impact factor: 5.156

7.  CD117+ Dendritic and Mast Cells Are Dependent on RasGRP4 to Function as Accessory Cells for Optimal Natural Killer Cell-Mediated Responses to Lipopolysaccharide.

Authors:  Saijun Zhou; Kumiko Tanaka; Meredith O'Keeffe; Miao Qi; Fatima El-Assaad; James C Weaver; Gang Chen; Christopher Weatherall; Ying Wang; Bill Giannakopoulos; Liming Chen; DeMint Yu; Matthew J Hamilton; Lislaine A Wensing; Richard L Stevens; Steven A Krilis
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240

8.  Mutated RAS-associating proteins and ERK activation in relapse/refractory diffuse large B cell lymphoma.

Authors:  Alexandre Benoit; Elisabeth Bou-Petit; Hsiang Chou; Melissa Lu; Cynthia Guilbert; Vincent Mingyi Luo; Sarit Assouline; Ryan D Morin; Svetlana Dmitrienko; Roger Estrada-Tejedor; Nathalie A Johnson; Koren K Mann
Journal:  Sci Rep       Date:  2022-01-17       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.